- Report
- August 2025
- 225 Pages
Global
From €2243EUR$2,500USD£1,969GBP
- Report
- December 2024
- 205 Pages
Global
From €2243EUR$2,500USD£1,969GBP
- Report
- June 2025
- 200 Pages
Global
From €4038EUR$4,500USD£3,544GBP
- Report
- June 2025
- 184 Pages
Global
From €4038EUR$4,500USD£3,544GBP
- Report
- February 2025
- 175 Pages
Global
From €4038EUR$4,500USD£3,544GBP
- Report
- November 2025
- 263 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 322 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 168 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 190 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 138 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 349 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 197 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 194 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 282 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 153 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 130 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 279 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 254 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 280 Pages
Global
From €5249EUR$5,850USD£4,607GBP
- Report
- November 2025
- 381 Pages
Global
From €5249EUR$5,850USD£4,607GBP

The Immune Disorders Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat immune system disorders. These drugs are used to treat a variety of conditions, including allergies, asthma, autoimmune diseases, and cancer. Immune Disorders Drugs are designed to target specific parts of the immune system, such as cytokines, antibodies, and T-cells, to reduce inflammation and improve the body's ability to fight off infection.
The Immune Disorders Drugs market is highly competitive, with many large pharmaceutical companies competing for market share. Some of the major players in the market include AbbVie, AstraZeneca, Bristol-Myers Squibb, GlaxoSmithKline, Merck, Novartis, Pfizer, and Roche. These companies are constantly researching and developing new drugs to treat immune system disorders, as well as improving existing treatments. Show Less Read more